Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.53% vs -7.69% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 75.00% vs -72.73% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 71.43% vs -22.22% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 40.20% vs 2.55% in Mar 2024
Compare Balance Sheet Results of Vaishali Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
26.09
1.20
24.89
2,074.17%
Share Warrants & Outstandings
Total Reserve
38.82
52.37
-13.55
-25.87%
Shareholder's Funds
64.92
53.57
11.35
21.19%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
7.36
3.04
4.32
142.11%
Secured Loans
7.36
0.62
6.74
1,087.10%
Unsecured Loans
0.00
2.42
-2.42
-100.00%
Deferred Tax Assets / Liabilities
-0.18
1.43
-1.61
-112.59%
Other Long Term Liabilities
0.42
0.74
-0.32
-43.24%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.26
0.38
-0.12
-31.58%
Total Non-Current Liabilities
4.69
5.59
-0.90
-16.10%
Current Liabilities
Trade Payables
27.14
9.83
17.31
176.09%
Other Current Liabilities
5.43
4.16
1.27
30.53%
Short Term Borrowings
7.46
1.05
6.41
610.48%
Short Term Provisions
0.01
0.03
-0.02
-66.67%
Total Current Liabilities
40.05
15.08
24.97
165.58%
Total Liabilities
109.66
74.24
35.42
47.71%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.46
46.41
-42.95
-92.54%
Less: Accumulated Depreciation
2.14
23.06
-20.92
-90.72%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.32
23.35
-22.03
-94.35%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
9.32
-9.32
-100.00%
Intangible assets under development
0.25
0.00
0.25
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.43
0.01
0.42
4,200.00%
Long Term Loans & Advances
1.05
0.00
1.05
0.00%
Other Non Current Assets
1.61
0.19
1.42
747.37%
Total Non-Current Assets
5.18
34.16
-28.98
-84.84%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.81
7.21
-2.40
-33.29%
Sundry Debtors
46.72
25.74
20.98
81.51%
Cash and Bank
1.84
2.19
-0.35
-15.98%
Other Current Assets
0.52
0.12
0.40
333.33%
Short Term Loans and Advances
50.59
4.82
45.77
949.59%
Total Current Assets
104.48
40.08
64.40
160.68%
Net Current Assets (Including Current Investments)
64.43
25.00
39.43
157.72%
Total Current Assets Excluding Current Investments
104.48
40.08
64.40
160.68%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
109.66
74.24
35.42
47.71%
Contingent Liabilities
0.00
3.26
-3.26
-100.00%
Total Debt
8.50
4.09
4.41
107.82%
Book Value per share (adjusted)
4.98
446.41
-441.43
-98.88%
Annual - Borrowings
Borrowings 11.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.53% vs -7.69% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.42 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 75.00% vs -72.73% in Mar 2024
Annual - Fixed Assets
Fixed Assets 1.32 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 71.43% vs -22.22% in Mar 2024
Annual - Investments
Investments 0.43 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 104.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 40.20% vs 2.55% in Mar 2024






